Probiotics for Gut Health

Probiotics are defined by the WHO and FAO as 'live microorganisms that, when administered in adequate amounts, confer a health benefit on the host'. The defining elements of this definition matter in practice: they must be live, they must be administered at adequate doses (typically 10^8 to 10^11 CFU), and there must be documented evidence of benefit for the specific strain at the specific dose for the specific application. The last point is the critical one. Probiotic strains are not interchangeable. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus Lcr35 are the same species but have different colonisation properties, mechanisms of action, and clinical evidence profiles. When reviewing probiotic products for gut health applications, the strain designation - the alphanumeric code following the species name - is as important as the species name itself.

Probiotics exert their effects through multiple overlapping mechanisms. Competitive exclusion: probiotic strains colonise mucosal surfaces and compete with pathogenic and commensal dysbiotic bacteria for binding sites and nutrients, limiting the expansion of potentially harmful species. Gut barrier enhancement: certain strains (particularly Lactobacillus plantarum 299v and Bifidobacterium longum 35624) upregulate tight junction proteins (occludin, claudin, ZO-1) that seal the epithelial barrier. Immune modulation: probiotics stimulate secretory IgA production at mucosal surfaces and modulate systemic cytokine balance - either promoting Th1/Treg responses (reducing inflammation) or stimulating innate immunity. Short-chain fatty acid production: probiotic bacteria ferment dietary fibre to produce SCFAs including butyrate, propionate, and acetate - the primary energy source for colonocytes and powerful regulators of colonic inflammation and motility.

The strains with the strongest evidence for general gut health and IBS include: Lactobacillus plantarum 299v, which has the most consistent replicated RCT evidence for IBS bloating and abdominal pain reduction among all single strains. Bifidobacterium longum 35624 (marketed as Alflorex), which uniquely normalises the IL-10/IL-12 cytokine ratio and has the largest single-strain IBS trial (362 patients, Whorwell et al. 2006). Lactobacillus rhamnosus GG, with the strongest evidence base for diarrhoea prevention (antibiotic-associated and infectious). Bifidobacterium lactis BB-12, the most studied Bifidobacterium strain overall with consistent evidence for constipation and stool frequency. Saccharomyces boulardii - technically a yeast, not a bacterium - with unique applicability during antibiotic courses (being unaffected by antibacterial agents). LOOM Gut Health is formulated around strains with the evidence to support the intended application.

Prebiotics are dietary fibres selectively fermented by beneficial gut bacteria, promoting their growth. The synbiotic approach - combining a probiotic with its preferred prebiotic substrate - is mechanistically superior to either alone. Inulin-type fructooligosaccharides (FOS) preferentially feed Bifidobacterium species; partially hydrolysed guar gum (PHGG) supports motility and is the best-evidenced prebiotic for IBS with mixed bowel habits. Psyllium husk provides soluble fibre and bulk for both constipation and diarrhoea-predominant IBS. When selecting a gut health supplement, the combination of targeted probiotic strains with a suitable prebiotic source ensures the probiotic organisms have the substrate to thrive post-ingestion.

Effective probiotic doses typically fall between 10^8 and 10^11 CFU per day for gut health applications. Labels should state CFU at time of use, not at manufacture (bacteria die during storage). Product labelling that guarantees CFU at expiry is the quality standard. Timing relative to meals varies by strain; most Lactobacillus and Bifidobacterium strains have better survival through gastric acid when taken with a meal. Saccharomyces boulardii is less acid-sensitive and can be taken anytime. Expect 4-8 weeks for meaningful clinical benefit in IBS; some effects (immune modulation, barrier reinforcement) may take longer. Consistency matters more than timing precision.